{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:18:03Z","timestamp":1787847483556,"version":"build-2784847793"},"reference-count":59,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The current antimicrobial therapy of bacterial infections of the central nervous system (CNS) in adults and pediatric patients is faced with many pitfalls as the drugs have to reach necessary levels in serum and cross the blood-brain barrier. Furthermore, several studies report that different factors such as the structure of the antimicrobial agent, the severity of disease, or the degree of inflammation play a significant role. Despite the available attempts to establish pharmacokinetic (PK) modeling to improve the required dosing regimen for adults and pediatric patients, conclusive recommendations for the best therapeutic strategies are still lacking. For instance, bacterial meningitis, the most common CNS infections, and ventriculitis, a severe complication of meningitis, are still associated with 10% and 30% mortality, respectively. Several studies report on the use of vancomycin and meropenem to manage meningitis and ventriculitis; therefore, this review aims to shed light on the current knowledge about their use in adults and pediatric patients. Consequently, studies published from 2015 until mid-July 2021 are included, and data about the study population, levels of drugs in serum and cerebrospinal fluid (CSF), and measured PK data in serum and CSF are provided. The overall aim is to provide the readers a recent reference that summarizes the pitfalls and success of the current therapy and emphasizes the importance of performing more studies to improve the clinical outcome of the current therapeutical approach.<\/jats:p>","DOI":"10.3390\/antibiotics11020173","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T01:41:59Z","timestamp":1643420519000},"page":"173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update"],"prefix":"10.3390","volume":"11","author":[{"given":"Franziska","family":"Schneider","sequence":"first","affiliation":[{"name":"Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Gessner","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2278-8586","authenticated-orcid":false,"given":"Nahed","family":"El-Najjar","sequence":"additional","affiliation":[{"name":"Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nic.2012.05.003","article-title":"Epidemiology of Central Nervous System Infection","volume":"22","author":"Riddell","year":"2012","journal-title":"Neuroimaging Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12098-017-2477-z","article-title":"Bacterial Infections of the Central Nervous System","volume":"86","author":"Suthar","year":"2019","journal-title":"Indian J. Pediatr."},{"key":"ref_3","first-page":"1679","article-title":"Bacterial Infections of the Central Nervous System","volume":"21","author":"Roos","year":"2015","journal-title":"Contin. Minneap. Minn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ncl.2008.03.013","article-title":"Update in the Diagnosis and Management of Central Nervous System Infections","volume":"26","author":"Ziai","year":"2008","journal-title":"Neurol. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14656566.2015.973851","article-title":"Treatment Strategies for Central Nervous System Infections: An Update","volume":"16","author":"Tan","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1038\/s41598-021-85382-4","article-title":"A Hospital-Based Study on Etiology and Prognosis of Bacterial Meningitis in Adults","volume":"11","author":"Sunwoo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ofab216","DOI":"10.1093\/ofid\/ofab216","article-title":"Ventriculitis: A Severe Complication of Central Nervous System Infections","volume":"8","author":"Revest","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhin.2016.09.008","article-title":"Healthcare Infection Society Working Party on Neurosurgical Infections Surveillance of Infection Associated with External Ventricular Drains: Proposed Methodology and Results from a Pilot Study","volume":"95","author":"Humphreys","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/CCM.0b013e31829a70a5","article-title":"Bundle of Measures for External Cerebral Ventricular Drainage-Associated Ventriculitis","volume":"42","author":"Chatzi","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00415-008-0059-8","article-title":"Nosocomial Ventriculitis and Meningitis in Neurocritical Care Patients","volume":"255","author":"Beer","year":"2008","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00701-018-3680-z","article-title":"Intrathecal Penetration of Meropenem and Vancomycin Administered by Continuous Infusion in Patients Suffering from Ventriculitis-a Retrospective Analysis","volume":"160","author":"Mader","year":"2018","journal-title":"Acta Neurochir."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pop.2018.05.007","article-title":"Central Nervous System Infections","volume":"45","author":"Giovane","year":"2018","journal-title":"Prim. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/qjmed\/hci047","article-title":"Delays in the Administration of Antibiotics Are Associated with Mortality from Adult Acute Bacterial Meningitis","volume":"98","author":"Proulx","year":"2005","journal-title":"QJM Mon. J. Assoc. Physicians"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 Infectious Diseases Society of America\u2019s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","article-title":"Pharmacokinetics of Antibacterial Agents in the CSF of Children and Adolescents","volume":"15","author":"Sullins","year":"2013","journal-title":"Paediatr. Drugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40262-013-0062-9","article-title":"Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid","volume":"52","author":"Gori","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of Drugs through the Blood-Cerebrospinal Fluid\/Blood-Brain Barrier for Treatment of Central Nervous System Infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/AAC.44.5.1356-1358.2000","article-title":"Cerebrospinal Fluid Penetration and Pharmacokinetics of Vancomycin Administered by Continuous Infusion to Mechanically Ventilated Patients in an Intensive Care Unit","volume":"44","author":"Bruguerolle","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","article-title":"Augmented Renal Clearance in Critically Ill Patients: A Systematic Review","volume":"57","author":"Barrasa","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/bcp.14657","article-title":"Population Pharmacokinetics of Vancomycin in Patients with External Ventricular Drain-Associated Ventriculitis","volume":"87","author":"Jalusic","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13318-017-0422-1","article-title":"Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy","volume":"43","author":"Li","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/AAC.00997-16","article-title":"Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery","volume":"60","author":"Lu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11096-006-9037-3","article-title":"Are Higher Vancomycin Doses Needed in Ventricle-External Shunted Patients?","volume":"28","author":"Pujal","year":"2006","journal-title":"Pharm. World Sci. PWS"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00228-017-2313-4","article-title":"Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients after Combined Intravenous and Intraventricular Administration","volume":"73","author":"Li","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00381-017-3623-7","article-title":"Monitoring Intraventricular Vancomycin for Ventriculostomy Access Device Infection in Preterm Infants","volume":"34","author":"Parasuraman","year":"2018","journal-title":"Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clineuro.2018.05.007","article-title":"Intra-Cerebrospinal Fluid Antibiotics to Treat Central Nervous System Infections: A Review and Update","volume":"170","author":"Mrowczynski","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00190-19","DOI":"10.1128\/CMR.00190-19","article-title":"Intrathecal Antibacterial and Antifungal Therapies","volume":"33","author":"Nau","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/sni.sni_81_17","article-title":"Intrathecal and Intraventricular Antibiotics for Postoperative Gram-Negative Meningitis and Ventriculitis","volume":"8","author":"Khan","year":"2017","journal-title":"Surg. Neurol. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1002\/jcph.1128","article-title":"Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs","volume":"58","author":"Le","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e0089721","DOI":"10.1128\/AAC.00897-21","article-title":"Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance","volume":"65","author":"He","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1542\/hpeds.2019-0287","article-title":"Vancomycin Dosing in Children with Overweight or Obesity: A Systematic Review and Meta-Analysis","volume":"10","author":"Khare","year":"2020","journal-title":"Hosp. Pediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bcp.13119","article-title":"Understanding and Applying Pharmacometric Modelling and Simulation in Clinical Practice and Research","volume":"83","author":"Standing","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/psp.2013.41","article-title":"Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery, and Development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_34","unstructured":"Mansoor, A., and Mahabadi, N. (2021). Volume of Distribution. StatPearls, StatPearls Publishing."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13054-016-1523-y","article-title":"Cerebrospinal Fluid Penetration of Meropenem in Neurocritical Care Patients with Proven or Suspected Ventriculitis: A Prospective Observational Study","volume":"20","author":"Blassmann","year":"2016","journal-title":"Crit. Care Lond. Engl."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/jac\/dky543","article-title":"CSF Penetration of Vancomycin in Critical Care Patients with Proven or Suspected Ventriculitis: A Prospective Observational Study","volume":"74","author":"Blassmann","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.diagmicrobio.2018.08.003","article-title":"Plasma and Cerebrospinal Fluid Population Pharmacokinetic Modeling and Simulation of Meropenem after Intravenous and Intrathecal Administration in Postoperative Neurosurgical Patients","volume":"93","author":"Li","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/AAC.03147-14","article-title":"Optimizing the Clinical Use of Vancomycin","volume":"60","author":"Molina","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin Revisited\u201460 Years Later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/491712","article-title":"The Pharmacokinetic and Pharmacodynamic Properties of Vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-017-0588-3","article-title":"Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?","volume":"57","author":"Kumta","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"ref_43","first-page":"105643","article-title":"Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study","volume":"158","author":"Parasuraman","year":"2021","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1097\/MD.0000000000000922","article-title":"An Investigation into the Vancomycin Concentration in the Cerebrospinal Fluid Due to Vancomycin Intraventricular Administration in Newborns: A Study of 13 Cases","volume":"94","author":"Matsunaga","year":"2015","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000488498","article-title":"Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci","volume":"53","author":"Gibson","year":"2018","journal-title":"Pediatr. Neurosurg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/CCM.0000000000000514","article-title":"Vancomycin-Associated Nephrotoxicity in the Critically Ill: A Retrospective Multivariate Regression Analysis","volume":"42","author":"Hanrahan","year":"2014","journal-title":"Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"812.e1","DOI":"10.1016\/j.wneu.2016.12.076","article-title":"Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care-Associated Meningitis?","volume":"99","author":"Mounier","year":"2017","journal-title":"World Neurosurg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jiac.2018.10.013","article-title":"Correlation between Vancomycin Penetration into Cerebrospinal Fluid and Protein Concentration in Cerebrospinal Fluid\/Serum Albumin Ratio","volume":"25","author":"Ishikawa","year":"2019","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.18433\/J3493F","article-title":"Association Between Vancomycin Blood Brain Barrier Penetration and Clinical Response in Postsurgical Meningitis","volume":"20","author":"Wang","year":"2017","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_50","first-page":"195","article-title":"Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion","volume":"17","author":"Taheri","year":"2018","journal-title":"Iran. J. Pharm. Res. IJPR"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jcpt.12770","article-title":"Comparation of Vancomycin Penetration into Cerebrospinal Fluid in Postoperative Intracranial Infection and Community-Acquired Meningitis Patients","volume":"44","author":"Cai","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13256-018-1646-7","article-title":"Staphylococcus Epidermidis Meningitis in the Absence of a Neurosurgical Device Secondary to Catheter-Related Bloodstream Infection: A Case Report and Review of the Literature","volume":"12","author":"Noguchi","year":"2018","journal-title":"J. Med. Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: A Review of Its Use in the Treatment of Serious Bacterial Infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0149-2918(04)80001-8","article-title":"Optimizing Antimicrobial Pharmacodynamics: Dosage Strategies for Meropenem","volume":"26","author":"Mattoes","year":"2004","journal-title":"Clin. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/jac\/dky128","article-title":"Plasma and CSF Pharmacokinetics of Meropenem in Neonates and Young Infants: Results from the NeoMero Studies","volume":"73","author":"Germovsek","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2019.06.021","article-title":"Cerebrospinal Pharmacokinetic and Pharmacodynamic Analysis of Efficacy of Meropenem in Paediatric Patients with Bacterial Meningitis","volume":"54","author":"Ohata","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Verscheijden, L.F.M., Koenderink, J.B., de Wildt, S.N., and Russel, F.G.M. (2019). Development of a Physiologically-Based Pharmacokinetic Pediatric Brain Model for Prediction of Cerebrospinal Fluid Drug Concentrations and the Influence of Meningitis. PLoS Comput. Biol., 15.","DOI":"10.1371\/journal.pcbi.1007117"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/phar.1567","article-title":"Pharmacokinetics of Continuous-Infusion Meropenem for the Treatment of Serratia Marcescens Ventriculitis in a Pediatric Patient","volume":"35","author":"Cies","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.wneu.2016.11.040","article-title":"Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery","volume":"98","author":"Zhang","year":"2017","journal-title":"World Neurosurg."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/2\/173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:10:03Z","timestamp":1760134203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/2\/173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":59,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["antibiotics11020173"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11020173","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]}}}